My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 129

    1.

    What is the benefit of increasing the sulfonylurea dose?

    Stenman S, Melander A, Groop PH, Groop LC.

    Ann Intern Med. 1993 Feb 1;118(3):169-72.PMID: 8417634 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).

    Abraira C, Henderson WG, Colwell JA, Nuttall FQ, Comstock JP, Emanuele NV, Levin SR, Sawin CT, Silbert CK.

    Diabetes Care. 1998 Apr;21(4):574-9.PMID: 9571345 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Multicenter, randomized, double-masked, parallel-group assessment of simultaneous glipizide/metformin as second-line pharmacologic treatment for patients with type 2 diabetes mellitus that is inadequately controlled by a sulfonylurea.

    Goldstein BJ, Pans M, Rubin CJ.

    Clin Ther. 2003 Mar;25(3):890-903.PMID: 12852706 [PubMed - indexed for MEDLINE]Related articles

    4.

    Efficacy, safety, and dose-response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM. Results of two multicenter, randomized, placebo-controlled clinical trials. The Glipizide Gastrointestinal Therapeutic System Study Group.

    Simonson DC, Kourides IA, Feinglos M, Shamoon H, Fischette CT.

    Diabetes Care. 1997 Apr;20(4):597-606.PMID: 9096986 [PubMed - indexed for MEDLINE]Related articles

    5.

    A prospective trial of risk factors for sulfonylurea-induced hypoglycemia in type 2 diabetes mellitus.

    Burge MR, Schmitz-Fiorentino K, Fischette C, Qualls CR, Schade DS.

    JAMA. 1998 Jan 14;279(2):137-43.PMID: 9440664 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Long-term randomized placebo-controlled double-blind therapeutic comparison of glipizide and glyburide. Glycemic control and insulin secretion during 15 months.

    Birkeland KI, Furuseth K, Melander A, Mowinckel P, Vaaler S.

    Diabetes Care. 1994 Jan;17(1):45-9.PMID: 8112188 [PubMed - indexed for MEDLINE]Related articles

    7.

    Combination insulin and sulfonylurea therapy in insulin-requiring type 2 diabetes mellitus.

    Feinglos MN, Thacker CR, Lobaugh B, DeAtkine DD, McNeill DB, English JS, Bursey DL.

    Diabetes Res Clin Pract. 1998 Mar;39(3):193-9.PMID: 9649951 [PubMed - indexed for MEDLINE]Related articles

    8.

    Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide.

    Roach, Koledova E, Metcalfe S, Hultman C, Milicevic Z; Romania/Russia Mix25 Study Group.

    Clin Ther. 2001 Oct;23(10):1732-44.PMID: 11726007 [PubMed - indexed for MEDLINE]Related articles

    9.

    The influence of multiple dosing and age on the pharmacokinetics and pharmacodynamics of glipizide in patients with type II diabetes mellitus.

    Jaber LA, Ducharme MP, Edwards DJ, Slaughter RL, Grunberger G.

    Pharmacotherapy. 1996 Sep-Oct;16(5):760-8.PMID: 8888072 [PubMed - indexed for MEDLINE]Related articles

    10.

    Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.

    Tîrgovişte CI, Străchinariu R, Farcaşiu E, Milicevic Z, Teodorescu G.

    Rom J Intern Med. 2003;41(2):153-62.PMID: 15526500 [PubMed - indexed for MEDLINE]Related articles

    11.

    Comparison of the effects of three insulinotropic drugs on plasma insulin levels after a standard meal.

    Cozma LS, Luzio SD, Dunseath GJ, Langendorg KW, Pieber T, Owens DR.

    Diabetes Care. 2002 Aug;25(8):1271-6.PMID: 12145220 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Results of a placebo-controlled study of the metabolic effects of the addition of metformin to sulfonylurea-treated patients. Evidence for a central role of adipose tissue.

    Abbasi F, Kamath V, Rizvi AA, Carantoni M, Chen YD, Reaven GM.

    Diabetes Care. 1997 Dec;20(12):1863-9.PMID: 9405908 [PubMed - indexed for MEDLINE]Related articles

    13.

    Effects of glipizide GITS and glibenclamide on metabolic control, hepatic glucose production, and insulin secretion in patients with type 2 diabetes.

    Go EH, Kyriakidou-Himonas M, Berelowitz M.

    Diabetes Metab Res Rev. 2004 May-Jun;20(3):225-31.PMID: 15133754 [PubMed - indexed for MEDLINE]Related articles

    14.

    Control of postprandial hyperglycemia: optimal use of short-acting insulin secretagogues.

    Carroll MF, Izard A, Riboni K, Burge MR, Schade DS.

    Diabetes Care. 2002 Dec;25(12):2147-52.PMID: 12453952 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Sustained-release versus immediate-release glipizide for treatment of type 2 diabetes mellitus in chinese patients: A randomized, double-blind, double-dummy, parallel-group, 12-week clinical study.

    Hsieh SH, Lin JD, Cheng HY, Ho C, Liou MJ.

    Clin Ther. 2006 Sep;28(9):1318-26.PMID: 17062305 [PubMed - indexed for MEDLINE]Related articles

    16.

    Bedtime insulin/daytime glipizide. Effective therapy for sulfonylurea failures in NIDDM.

    Shank ML, Del Prato S, DeFronzo RA.

    Diabetes. 1995 Feb;44(2):165-72.PMID: 7859936 [PubMed - indexed for MEDLINE]Related articles

    17.

    Metabolic effects of chronic glipizide gastrointestinal therapeutic system on serum glucose, insulin secretion, insulin sensitivity, and hepatic insulin extraction in glucose-tolerant, first-degree relatives of African American patients with type 2 diabetes: new insights on mechanisms of action.

    Osei K, Rhinesmith S, Gaillard T, Schuster D.

    Metabolism. 2003 May;52(5):565-72.PMID: 12759885 [PubMed - indexed for MEDLINE]Related articles

    18.

    Beneficial metabolic effects of chronic glipizide in obese African Americans with impaired glucose tolerance: implications for primary prevention of type 2 diabetes.

    Osei K, Rhinesmith S, Gaillard T, Schuster D.

    Metabolism. 2004 Apr;53(4):414-22.PMID: 15045685 [PubMed - indexed for MEDLINE]Related articles

    19.

    Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial.

    Testa MA, Simonson DC.

    JAMA. 1998 Nov 4;280(17):1490-6.PMID: 9809729 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Pharmacokinetics and pharmacodynamics of glipizide after once-daily and divided doses.

    Kradjan WA, Takeuchi KY, Opheim KE, Wood FC Jr.

    Pharmacotherapy. 1995 Jul-Aug;15(4):465-71.PMID: 7479199 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity